In this review, we aim to summarize what is known about the role of NUDT5 and some other members of the NUDT family, in cancer growth and we will discuss how the use of global omic datasets could be integrated to provide additional insight into drug discovery opportunities for aggressive HR+ breast cancers and other cancer types. This evidence concerns the gene NUDT5 and breast carcinoma.